BRY — Bri-Chem Income Statement
0.000.00%
- CA$5.84m
- CA$25.52m
- CA$83.07m
Annual income statement for Bri-Chem, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
| 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M | 
| Source: | ARS | ARS | ARS | ARS | ARS | 
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS | 
| Status: | Final | Final | Final | Final | Final | 
| Revenue | |||||
| Total Revenue | 45.2 | 60.4 | 105 | 106 | 83.1 | 
| Cost of Revenue | |||||
| Gross Profit | 7.33 | 12.2 | 21.1 | 18.7 | 14.4 | 
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 50.1 | 59.3 | 99.2 | 105 | 87.3 | 
| Operating Profit | -4.92 | 1.15 | 5.27 | 0.85 | -4.19 | 
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -5.12 | 1.29 | 4.62 | 1.41 | -4.97 | 
| Provision for Income Taxes | |||||
| Net Income After Taxes | -5.15 | 1.32 | 8.64 | 0.909 | -3.85 | 
| Net Income Before Extraordinary Items | |||||
| Net Income | -5.15 | 1.32 | 8.64 | 0.909 | -3.85 | 
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -5.15 | 1.32 | 8.64 | 0.909 | -3.85 | 
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.212 | 0.048 | 0.327 | 0.034 | -0.145 |